ID   S10A9_RAT               Reviewed;         113 AA.
AC   P50116; Q761U7;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   24-JUL-2024, entry version 166.
DE   RecName: Full=Protein S100-A9;
DE   AltName: Full=Calgranulin-B;
DE   AltName: Full=Migration inhibitory factor-related protein 14;
DE            Short=MRP-14;
DE            Short=p14;
DE   AltName: Full=Myeloid-related protein 14;
DE   AltName: Full=S100 calcium-binding protein A9;
GN   Name=S100a9; Synonyms=Mrp14;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=Lewis/N; TISSUE=Peritoneal cavity;
RX   PubMed=8343166; DOI=10.1006/bbrc.1993.1895;
RA   Imamichi T., Uchida I., Wahl S.M., McCartney-Francis N.;
RT   "Expression and cloning of migration inhibitory factor-related protein
RT   (MRP)8 and MRP14 in arthritis-susceptible rats.";
RL   Biochem. Biophys. Res. Commun. 194:819-825(1993).
RN   [2]
RP   PROTEIN SEQUENCE OF 2-57; 62-65 AND 72-113, MASS SPECTROMETRY, ACETYLATION
RP   AT ALA-2, AND METHYLATION AT HIS-107.
RC   TISSUE=Spleen;
RX   PubMed=9570842; DOI=10.1006/abio.1997.2601;
RA   Raftery M.J., Geczy C.L.;
RT   "Identification of posttranslational modifications and cDNA sequencing
RT   errors in the rat S100 proteins MRP8 and 14 using electrospray ionization
RT   mass spectrometry.";
RL   Anal. Biochem. 258:285-292(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 3-113, PROTEIN SEQUENCE OF 11-25; 38-67;
RP   81-90 AND 94-112, FUNCTION, SUBUNIT, AND TISSUE SPECIFICITY.
RC   STRAIN=Wistar; TISSUE=Macrophage, and Peritoneal cavity;
RX   PubMed=15153104; DOI=10.1111/j.1432-1033.2004.04129.x;
RA   Shibata F., Miyama K., Shinoda F., Mizumoto J., Takano K., Nakagawa H.;
RT   "Fibroblast growth-stimulating activity of S100A9 (MRP-14).";
RL   Eur. J. Biochem. 271:2137-2143(2004).
RN   [4]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=21487906; DOI=10.1007/s10753-011-9330-8;
RA   Koike A., Arai S., Yamada S., Nagae A., Saita N., Itoh H., Uemoto S.,
RA   Totani M., Ikemoto M.;
RT   "Dynamic mobility of immunological cells expressing S100A8 and S100A9 in
RT   vivo: a variety of functional roles of the two proteins as regulators in
RT   acute inflammatory reaction.";
RL   Inflammation 35:409-419(2012).
CC   -!- FUNCTION: S100A9 is a calcium- and zinc-binding protein which plays a
CC       prominent role in the regulation of inflammatory processes and immune
CC       response (PubMed:15153104, PubMed:21487906). It can induce neutrophil
CC       chemotaxis, adhesion, can increase the bactericidal activity of
CC       neutrophils by promoting phagocytosis via activation of SYK, PI3K/AKT,
CC       and ERK1/2 and can induce degranulation of neutrophils by a MAPK-
CC       dependent mechanism (By similarity). Predominantly found as
CC       calprotectin (S100A8/A9) which has a wide plethora of intra- and
CC       extracellular functions (By similarity). The intracellular functions
CC       include: facilitating leukocyte arachidonic acid trafficking and
CC       metabolism, modulation of the tubulin-dependent cytoskeleton during
CC       migration of phagocytes and activation of the neutrophilic NADPH-
CC       oxidase (By similarity). Participates also in regulatory T-cell
CC       differentiation together with CD69. Activates NADPH-oxidase by
CC       facilitating the enzyme complex assembly at the cell membrane,
CC       transferring arachidonic acid, an essential cofactor, to the enzyme
CC       complex and S100A8 contributes to the enzyme assembly by directly
CC       binding to NCF2/P67PHOX (By similarity). The extracellular functions
CC       involve pro-inflammatory, antimicrobial, oxidant-scavenging and
CC       apoptosis-inducing activities (PubMed:21487906). Its pro-inflammatory
CC       activity includes recruitment of leukocytes, promotion of cytokine and
CC       chemokine production, and regulation of leukocyte adhesion and
CC       migration (By similarity). Acts as an alarmin or a danger associated
CC       molecular pattern (DAMP) molecule and stimulates innate immune cells
CC       via binding to pattern recognition receptors such as Toll-like receptor
CC       4 (TLR4) and receptor for advanced glycation endproducts (AGER) (By
CC       similarity). Binding to TLR4 and AGER activates the MAP-kinase and NF-
CC       kappa-B signaling pathways resulting in the amplification of the pro-
CC       inflammatory cascade (By similarity). Has antimicrobial activity
CC       towards bacteria and fungi and exerts its antimicrobial activity
CC       probably via chelation of Zn(2+) which is essential for microbial
CC       growth (By similarity). Can induce cell death via autophagy and
CC       apoptosis and this occurs through the cross-talk of mitochondria and
CC       lysosomes via reactive oxygen species (ROS) and the process involves
CC       BNIP3 (By similarity). Can regulate neutrophil number and apoptosis by
CC       an anti-apoptotic effect; regulates cell survival via ITGAM/ITGB and
CC       TLR4 and a signaling mechanism involving MEK-ERK (By similarity). Its
CC       role as an oxidant scavenger has a protective role in preventing
CC       exaggerated tissue damage by scavenging oxidants (By similarity). The
CC       iNOS-S100A8/A9 transnitrosylase complex is proposed to direct selective
CC       inflammatory stimulus-dependent S-nitrosylation of multiple targets
CC       such as GAPDH, NXA5, EZR, MSN and VIM by recognizing a [IL]-x-C-x-x-
CC       [DE] motif (By similarity). {ECO:0000250|UniProtKB:P06702,
CC       ECO:0000269|PubMed:15153104, ECO:0000269|PubMed:21487906}.
CC   -!- SUBUNIT: Homodimer. Preferentially exists as a heterodimer or
CC       heterotetramer with S100A8 known as calprotectin (S100A8/A9) (By
CC       similarity). S100A9 interacts with ATP2A2 (By similarity). S100A9
CC       interacts with AGER, and with the heterodimeric complex formed by TLR4
CC       and LY96 in the presence of calcium and/or zinc ions. S100A9 binds
CC       quinoline-3-carboxamides in the presence of calcium and/or zinc ions.
CC       S100A9 interacts with amyloid-beta protein 40. Calprotectin (S100A8/9)
CC       interacts with CEACAM3 and tubulin filaments in a calcium-dependent
CC       manner. Heterotetrameric calprotectin (S100A8/A9) interacts with ANXA6
CC       and associates with tubulin filaments in activated monocytes.
CC       Calprotectin (S100A8/9) interacts with NCF2/P67PHOX, RAC1, RAC2, CYBA
CC       and CYBB. Calprotectin (S100A8/9) interacts with NOS2 to form the iNOS-
CC       S100A8/A9 transnitrosylase complex; induced by LDL(ox) (By similarity).
CC       Calprotectin (S100A8/9) interacts with CD69 (By similarity).
CC       {ECO:0000250|UniProtKB:P06702, ECO:0000250|UniProtKB:P31725}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:P06702}.
CC       Cytoplasm {ECO:0000250|UniProtKB:P06702}. Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:P06702}. Cell membrane
CC       {ECO:0000269|PubMed:21487906}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:21487906}. Note=Predominantly localized in the
CC       cytoplasm. Upon elevation of the intracellular calcium level,
CC       translocated from the cytoplasm to the cytoskeleton and the cell
CC       membrane. Upon neutrophil activation or endothelial adhesion of
CC       monocytes, is secreted via a microtubule-mediated, alternative pathway.
CC       {ECO:0000250|UniProtKB:P06702}.
CC   -!- TISSUE SPECIFICITY: Highly expressed at sites of inflammation.
CC       {ECO:0000269|PubMed:15153104, ECO:0000269|PubMed:8343166}.
CC   -!- PTM: Phosphorylated. Phosphorylation inhibits activation of tubulin
CC       polymerization. {ECO:0000250|UniProtKB:P06702}.
CC   -!- PTM: Methylation at His-107 by METTL9 reduces zinc-binding without
CC       affecting heterodimerization with S100A8.
CC       {ECO:0000250|UniProtKB:P31725}.
CC   -!- MASS SPECTROMETRY: Mass=13069; Mass_error=2; Method=Electrospray;
CC       Evidence={ECO:0000269|PubMed:9570842};
CC   -!- SIMILARITY: Belongs to the S-100 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L18948; AAA18214.1; -; mRNA.
DR   EMBL; AB118215; BAC82423.1; -; mRNA.
DR   PIR; JN0686; JN0686.
DR   RefSeq; NP_446039.1; NM_053587.1.
DR   AlphaFoldDB; P50116; -.
DR   SMR; P50116; -.
DR   IntAct; P50116; 1.
DR   STRING; 10116.ENSRNOP00000015351; -.
DR   iPTMnet; P50116; -.
DR   PhosphoSitePlus; P50116; -.
DR   PaxDb; 10116-ENSRNOP00000015351; -.
DR   GeneID; 94195; -.
DR   KEGG; rno:94195; -.
DR   UCSC; RGD:620267; rat.
DR   AGR; RGD:620267; -.
DR   CTD; 6280; -.
DR   RGD; 620267; S100a9.
DR   eggNOG; ENOG502SA01; Eukaryota.
DR   HOGENOM; CLU_138624_6_0_1; -.
DR   InParanoid; P50116; -.
DR   OrthoDB; 4607525at2759; -.
DR   PhylomeDB; P50116; -.
DR   TreeFam; TF332727; -.
DR   Reactome; R-RNO-5668599; RHO GTPases Activate NADPH Oxidases.
DR   Reactome; R-RNO-5686938; Regulation of TLR by endogenous ligand.
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   Reactome; R-RNO-6799990; Metal sequestration by antimicrobial proteins.
DR   PRO; PR:P50116; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:1990660; C:calprotectin complex; ISO:RGD.
DR   GO; GO:0001533; C:cornified envelope; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:1990662; C:S100A9 complex; ISO:RGD.
DR   GO; GO:0016209; F:antioxidant activity; IEA:UniProtKB-KW.
DR   GO; GO:0005509; F:calcium ion binding; IBA:GO_Central.
DR   GO; GO:0048306; F:calcium-dependent protein binding; IBA:GO_Central.
DR   GO; GO:0030036; P:actin cytoskeleton organization; ISO:RGD.
DR   GO; GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; ISS:UniProtKB.
DR   GO; GO:0061844; P:antimicrobial humoral immune response mediated by antimicrobial peptide; IBA:GO_Central.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0014002; P:astrocyte development; ISO:RGD.
DR   GO; GO:0035425; P:autocrine signaling; IGI:ARUK-UCL.
DR   GO; GO:0006914; P:autophagy; ISS:UniProtKB.
DR   GO; GO:0002544; P:chronic inflammatory response; IEP:RGD.
DR   GO; GO:0043542; P:endothelial cell migration; IBA:GO_Central.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0030595; P:leukocyte chemotaxis; ISO:RGD.
DR   GO; GO:0002523; P:leukocyte migration involved in inflammatory response; ISS:UniProtKB.
DR   GO; GO:0070488; P:neutrophil aggregation; ISS:UniProtKB.
DR   GO; GO:0030593; P:neutrophil chemotaxis; ISS:UniProtKB.
DR   GO; GO:0002790; P:peptide secretion; ISO:RGD.
DR   GO; GO:0030194; P:positive regulation of blood coagulation; ISO:RGD.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; ISS:UniProtKB.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0002793; P:positive regulation of peptide secretion; ISO:RGD.
DR   GO; GO:0045113; P:regulation of integrin biosynthetic process; ISO:RGD.
DR   GO; GO:0006417; P:regulation of translation; ISO:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0010043; P:response to zinc ion; IEP:RGD.
DR   CDD; cd05030; calgranulins; 1.
DR   Gene3D; 1.10.238.10; EF-hand; 1.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR001751; S100/CaBP7/8-like_CS.
DR   InterPro; IPR013787; S100_Ca-bd_sub.
DR   PANTHER; PTHR11639:SF79; PROTEIN S100-A9; 1.
DR   PANTHER; PTHR11639; S100 CALCIUM-BINDING PROTEIN; 1.
DR   Pfam; PF01023; S_100; 1.
DR   SMART; SM00054; EFh; 1.
DR   SMART; SM01394; S_100; 1.
DR   SUPFAM; SSF47473; EF-hand; 1.
DR   PROSITE; PS50222; EF_HAND_2; 1.
DR   PROSITE; PS00303; S100_CABP; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Antimicrobial; Antioxidant; Apoptosis; Autophagy; Calcium;
KW   Cell membrane; Chemotaxis; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; Immunity; Inflammatory response;
KW   Innate immunity; Membrane; Metal-binding; Methylation; Phosphoprotein;
KW   Reference proteome; Repeat; Secreted; Zinc.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:9570842"
FT   CHAIN           2..113
FT                   /note="Protein S100-A9"
FT                   /id="PRO_0000143999"
FT   DOMAIN          13..48
FT                   /note="EF-hand 1"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          55..90
FT                   /note="EF-hand 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         21
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P06702"
FT   BINDING         24
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /ligand_note="low affinity"
FT                   /evidence="ECO:0000250|UniProtKB:P06702"
FT   BINDING         29
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /ligand_note="low affinity"
FT                   /evidence="ECO:0000250|UniProtKB:P06702"
FT   BINDING         31
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P06702"
FT   BINDING         32
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /ligand_note="low affinity"
FT                   /evidence="ECO:0000250|UniProtKB:P06702"
FT   BINDING         37
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /ligand_note="low affinity"
FT                   /evidence="ECO:0000250|UniProtKB:P06702"
FT   BINDING         68
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /ligand_note="high affinity"
FT                   /evidence="ECO:0000250|UniProtKB:P06702"
FT   BINDING         70
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /ligand_note="high affinity"
FT                   /evidence="ECO:0000250|UniProtKB:P06702"
FT   BINDING         72
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /ligand_note="high affinity"
FT                   /evidence="ECO:0000250|UniProtKB:P06702"
FT   BINDING         74
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /ligand_note="high affinity"
FT                   /evidence="ECO:0000250|UniProtKB:P06702"
FT   BINDING         79
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /ligand_note="high affinity"
FT                   /evidence="ECO:0000250|UniProtKB:P06702"
FT   BINDING         92
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P06702"
FT   BINDING         96
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P06702"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|PubMed:9570842"
FT   MOD_RES         107
FT                   /note="Pros-methylhistidine"
FT                   /evidence="ECO:0000269|PubMed:9570842"
FT   CONFLICT        17
FT                   /note="I -> Q (in Ref. 3; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        24
FT                   /note="S -> C (in Ref. 3; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        106
FT                   /note="S -> R (in Ref. 1; AAA18214)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   113 AA;  13145 MW;  6C3A0044A7AEC4FA CRC64;
     MAAKTGSQLE RSISTIINVF HQYSRKYGHP DTLNKAEFKE MVNKDLPNFL KREKRNENLL
     RDIMEDLDTN QDNQLSFEEC MMLMGKLIFA CHEKLHENNP RGHDHSHGKG CGK
//
